Login / Signup

Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report.

Fumisato MaesakaYasushi NakaiMitsuru TomizawaTakuya OwariMakito MiyakeTakeshi InoueSatoshi AnaiNobumichi TanakaKiyohide Fujimoto
Published in: IJU case reports (2019)
Amrubicin could serve as a second-line chemotherapeutic agent against small cell carcinoma of the prostate.
Keyphrases
  • prostate cancer
  • benign prostatic hyperplasia